Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...
Главные авторы: | Link, A, Bachmann, M |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2010
|
Схожие документы
-
Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.
по: Jennings, G, и др.
Опубликовано: (2009) -
Anticytokine Autoantibodies and Fungal Infections
по: Shanthi Kappagoda, и др.
Опубликовано: (2023-07-01) -
Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
по: Vijaya Knight, и др.
Опубликовано: (2016-01-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
по: M.M. Venediktova, и др.
Опубликовано: (2011-09-01) -
CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
по: M.M. Venediktova, и др.
Опубликовано: (2011-01-01)